Skip to Main Content

Paper Details

Functional and genetic screening of acute myeloid leukemia associated with mediastinal germ cell tumor identifies MEK inhibitor as an active clinical agent.
J Hematol Oncol
22
2016
Author NameAffiliation
Jessica LeonardOregon Health & Science University
Jennifer DunlapOregon Health & Science University
Brandon Hayes-LattinCenter for Hematologic Malignancies, Oregon Health and Science University
Jeffrey W Tyner
Jeffrey W TynerKnight Cancer Institute, Oregon Health & Science University
Elie TraerCenter for Hematologic Malignancies, Oregon Health and Science University
Elie TraerKnight Cancer Institute, Oregon Health & Science University
  • 1 - 7

Datasets

Release 1.2